Glenview Capital Management’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-8,603,438
Closed -$817M – 60
2018
Q3
$817M Buy
8,603,438
+1,623,869
+23% +$138M 5.19% 1
2018
Q2
$539M Buy
6,979,569
+2,337,583
+50% +$175M 3.68% 10
2018
Q1
$321M Buy
+4,641,986
New +$354M 1.88% 22
2016
Q4
– Sell
-640,960
Closed -$45.2M – 54
2016
Q3
$45.2M Buy
640,960
+568,838
+789% +$42.5M 0.32% 44
2016
Q2
$5.47M Buy
+72,122
New +$5.3M 0.04% 46

Other funds holding ESRX

Glenview Capital Management's ESRX Position: Q4 2018 in Review

Glenview Capital Management sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 8,603,438 shares — an estimated $817M sold.

Glenview Capital Management first reported a position in ESRX in Q2 2016 and held it in 5 quarters. The position peaked at $817M in Q3 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Glenview Capital Management reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Glenview Capital Management sold 8,603,438 Express Scripts Holding Company shares in Q4 2018, an estimated $817M.
  • Glenview Capital Management first reported a position in Express Scripts Holding Company in Q2 2016 and held it in 5 quarters.
  • Glenview Capital Management's Express Scripts Holding Company position peaked at $817M in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Glenview Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.